Literature DB >> 16740205

Identifying patients who need close monitoring during and after upper airway surgery for obstructive sleep apnoea.

K P Pang1.   

Abstract

Potentially serious complications have been documented in patients undergoing upper airway surgery for obstructive sleep apnoea (OSA). Consensus is lacking regarding peri- and post-operative monitoring and identification of those patients likely to suffer post-operative complications. This retrospective review of 118 patients treated and 152 surgical procedures undertaken, from January 1998 to December 2003, addresses this issue. The overall peri- and post-operative complication rate was 13.8 per cent, with one patient experiencing upper airway compromise, five patients experiencing post-operative oxygen desaturation within 150 minutes of extubation, six patients experiencing persistent hypertension and four patients suffering secondary haemorrhage. All patients were treated accordingly and recovered well, with no mortality. From these results, it is concluded that patients with severe OSA (apnoea-hypopnoea index > 60 and lowest oxygen saturation < 80 per cent) are at higher risk of post-operative oxygen desaturation. Post-operative hypertension is more likely in patients with a prior history of hypertension. Routine post-operative admission to an intensive care unit for all OSA patients is unnecessary (including patients with severe OSA). However, all patients with OSA should be closely monitored in the post-anaesthesia care area for at least three hours after surgery; based on the outcome of this period and the clinical judgment of the clinician, the patient can then be observed overnight in either the high dependency unit or on a general ward. Patients with mild OSA may be admitted to the 23-hour ambulatory unit post-operatively. Use of continuous positive airway pressure in the immediate post-operative period can reduce the incidence of post-operative respiratory compromise and complications and is strongly recommended.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740205     DOI: 10.1017/S0022215106001617

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  6 in total

1.  Randomized, Double-Blind Study of the Effect of Intraoperative Intravenous Lidocaine on the Opioid Consumption and Criteria for Hospital Discharge After Bariatric Surgery.

Authors:  Rioko K Sakata; Roclides C de Lima; Jose A Valadão; Plinio C Leal; Ed Cr Moura; Vitor P Cruz; Caio Mb de Oliveira
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

Review 2.  Effects and side-effects of surgery for snoring and obstructive sleep apnea--a systematic review.

Authors:  Karl A Franklin; Heidi Anttila; Susanna Axelsson; Thorarinn Gislason; Paula Maasilta; Kurt I Myhre; Nina Rehnqvist
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

Review 3.  Postoperative apnea, respiratory strategies, and pathogenesis mechanisms: a review.

Authors:  Alan D Kaye; McKenzie Mayo Hollon; Nalini Vadivelu; Gopal Kodumudi; Rachel J Kaye; Franklin Rivera Bueno; Amir R Baluch
Journal:  J Anesth       Date:  2012-11-21       Impact factor: 2.078

4.  The incidence of early post-operative complications following uvulopalatopharyngoplasty: identification of predictive risk factors.

Authors:  Thileeban Kandasamy; Erin D Wright; John Fuller; Brian W Rotenberg
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-02-06

5.  Association between self reported snoring, STOP questionnaire and postoperative pulmonary complications in patients submitted to ortophaedic surgery.

Authors:  Ahmet Ursavaş; Tahir Güven; Funda Coskun; Ercüment Ege; Aysun Yılmazlar
Journal:  Multidiscip Respir Med       Date:  2013-01-18

6.  Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association.

Authors:  Stuart G MacKay; Richard Lewis; Doug McEvoy; Simon Joosten; Nicolette R Holt
Journal:  Respirology       Date:  2020-11-15       Impact factor: 6.424

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.